Article
Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses.
Vaccine - 2 Sept 2011
Mantel N, Girerd Y, Geny C, Bernard I, Pontvianne J, Lang J, Barban V
Abstract excerpt
A tetravalent dengue vaccine based on four live, attenuated, chimeric viruses (CYD1-4), constructed by replacing the genes coding for premembrane (prM) and envelope (E) proteins of the yellow fever (YF)-17D vaccine strain with those of the four serotypes of dengue virus, is in clinical phase III evaluation. We assessed the vaccine's genetic stability by fully sequencing each vaccine virus throughout the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
